Mitrix
1 known investors
Mitrix Bio develops bioreactor-grown mitochondria encased in vesicles ("Mitlets") for transplantation to address mitochondrial dysfunction in age-related diseases. The company targets treatment of conditions including Alzheimer's, retinal disease, and immune senescence by supplementing cellular energy in patients over 55.
BiotechDeep TechLongevity
Investors · 1
In the news
- Mitrix - 2025 Company Profile, Funding & Competitors - Tracxntracxn.com · 2021
- “Whole-body mitochondrial transfusion” start-up lands funding - Longevity.Technologylongevity.technology · 2021